Compounds > naltrexone

naltrexone and Lung Neoplasms

naltrexone has been researched along with Lung Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, G; Low, PS1
Jatlow, PI; Mayne, ST; O'Malley, SS; Wu, R1
Aung, HH; Li, XL; McEntee, E; Sun, S; Tong, R; Wang, CZ; Xie, JT; Yuan, CS1
Chen, YL; Law, PY; Loh, HH1
Hodgson, DM; Taylor, AN; Yirmiya, R1
Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S1

Trials

1 trial(s) available for naltrexone and Lung Neoplasms

ArticleYear
Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:8

    Topics: Administration, Cutaneous; Adult; Antioxidants; Bilirubin; Cardiovascular Diseases; Counseling; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naltrexone; Nicotine; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome

2014

Other Studies

5 other study(ies) available for naltrexone and Lung Neoplasms

ArticleYear
Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.
    Bioorganic & medicinal chemistry letters, 2017, 05-01, Volume: 27, Issue:9

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Drug Delivery Systems; HEK293 Cells; Humans; Ligands; Lung Neoplasms; Mice; Models, Molecular; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, mu; Tissue Distribution

2017
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Lung Neoplasms; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Tumor Cells, Cultured

2009
Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.
    Cancer research, 2004, Dec-01, Volume: 64, Issue:23

    Topics: Apoptosis; Binding Sites; Carcinoma, Small Cell; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Gene Expression; Humans; Lung Neoplasms; Naltrexone; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction

2004
Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins.
    Journal of neuroimmunology, 2001, Sep-03, Volume: 119, Issue:1

    Topics: Adenocarcinoma; Animals; Brain; Cyclooxygenase Inhibitors; Diclofenac; Ibuprofen; Injections, Intraventricular; Interleukin-1; Lung Neoplasms; Male; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Neural Pathways; Norepinephrine; Prostaglandins; Rats; Rats, Inbred F344

2001
Metastasis and neuroendocrine system in stressed mice.
    Annals of the New York Academy of Sciences, 1992, Apr-15, Volume: 650

    Topics: Animals; Bromocriptine; Carcinoma; Female; Guanethidine; Lung Neoplasms; Mice; Mitotane; Naltrexone; Neoplasm Metastasis; Neuroimmunomodulation; Reserpine; Stress, Psychological

1992